The use of larger species in later-stage, non-GLP drug discovery is a crucial step when progressing your lead candidates towards the clinic. Whether being used for pharmacokinetic and safety translatability across species, or confirmation of target engagement and efficacy from prior rodent models, a larger species can provide a key dataset for IND submission. Our Discovery Services group has decades of experience with a wide range of large animal models in locations that span the globe. We can perform the research needed in these models to shepherd your drug discovery program towards the clinic.
For more information, visit the Source℠, a portal that provides registered users with direct access to the scientific resources that Charles River has developed over the years.